BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Coagulation, Obesity, Embryo, Laser capture microdissection, Fluoxetine, rs7903146, LEP)
Bookmark Forward

QuickView for Nfatc1 (gene)


Body Atlas

Most Correlated Tissues

  1. Ciliary ganglion
  2. B lymphocyte (naive) of spleen
  3. B lymphocyte (IgM memory) of spleen
  4. Atrioventricular node
  5. T Lymphocyte (regulatory) of peripheral blood
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Periodontitis
  2. Listeriosis
  3. Parvovirus infection
  4. Toxoplasmosis
  5. Meningitis
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Epirizole
  2. 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
  3. Amikacin
  4. CCL2 protein, human
  5. Meclizine
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. MARCH6
  2. NFATC1
  3. GSDME
  4. DAP
  5. PA2G4
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Extracellular C1qbp inhibits myogenesis by suppressing NFATc1.
  2. The serine synthesis pathway drives osteoclast differentiation through epigenetic regulation of NFAT…
  3. Recent advances of NFATc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential…
  4. Essentiality of Nfatc1 short isoform in osteoclast differentiation and its self-regulation.
  5. Vascular Neoplasms With NFATC1/C2 Gene Alterations : Expanding the Clinicopathologic and Molecular C…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Physiopathology of Prosthetic Joint Infections
  2. DNA Methylation Analysis in Acute Coronary Syndrome and Atrial Fibrillation: DIANA Clinical Trial
  3. Treg Modulation With CD28 and IL-6 Receptor Antagonists
  4. Identification of Circulating microRNAs in Adolescent Idiopathic Scoliosis
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.